Scarica l'app Stockscreener
111.90
2.37%
-2.72
Dopo l'orario di chiusura:
111.95
0.05
+0.04%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$114.62
Aprire:
$113.74
Volume 24 ore:
7.00M
Relative Volume:
0.64
Capitalizzazione di mercato:
$276.38B
Reddito:
$64.93B
Utile/perdita netta:
$18.26B
Rapporto P/E:
15.38
EPS:
7.2751
Flusso di cassa netto:
$12.36B
1 W Prestazione:
-6.02%
1M Prestazione:
-3.84%
6M Prestazione:
+27.90%
1 anno Prestazione:
+40.16%
Intervallo 1D:
$111.50
$114.03
Intervallo di 1 settimana:
$111.50
$119.36
Portata 52W:
$73.31
$125.14
Merck Co Inc Stock (MRK) Company Profile
Nome
Merck Co Inc
Settore
Industria
Telefono
908-740-4000
Indirizzo
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, AZN, NVS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
111.90 | 276.38B | 64.93B | 18.26B | 12.36B | 7.2751 |
LLY
Lilly Eli Co
|
883.96 | 789.69B | 65.18B | 20.64B | 5.96B | 22.59 |
JNJ
Johnson Johnson
|
227.50 | 547.64B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
198.71 | 351.47B | 61.16B | 4.19B | 17.82B | 2.3614 |
AZN
Astrazeneca Plc
|
189.75 | 294.27B | 58.80B | 10.24B | 8.98B | 3.2788 |
NVS
Novartis Ag Adr
|
145.47 | 277.58B | 54.72B | 14.02B | 15.32B | 7.1855 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-02-20 | Iniziato | Barclays | Overweight |
| 2026-02-13 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2026-01-08 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-10-13 | Ripresa | Citigroup | Neutral |
| 2025-09-17 | Downgrade | Berenberg | Buy → Hold |
| 2025-05-14 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-08 | Downgrade | Truist | Buy → Hold |
| 2024-12-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Ripresa | BofA Securities | Buy |
| 2024-12-04 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-11 | Downgrade | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-03-11 | Downgrade | Societe Generale | Hold → Sell |
| 2024-01-04 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-27 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Hold |
| 2023-04-13 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-03-28 | Downgrade | Societe Generale | Buy → Hold |
| 2023-03-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Iniziato | Jefferies | Buy |
| 2023-02-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-10-10 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-09-14 | Aggiornamento | Berenberg | Hold → Buy |
| 2022-07-06 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Ripresa | SVB Leerink | Outperform |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Iniziato | Goldman | Buy |
| 2021-12-16 | Iniziato | Daiwa Securities | Neutral |
| 2021-12-13 | Downgrade | UBS | Buy → Neutral |
| 2021-12-09 | Iniziato | Wells Fargo | Overweight |
| 2021-12-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-11-29 | Downgrade | Citigroup | Buy → Neutral |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-11-01 | Aggiornamento | Argus | Hold → Buy |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-05-20 | Downgrade | Argus | Buy → Hold |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-08-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-06-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-16 | Iniziato | SVB Leerink | Outperform |
| 2019-07-03 | Iniziato | Mizuho | Buy |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-05-13 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Reiterato | Citigroup | Buy |
| 2018-10-09 | Ripresa | Guggenheim | Buy |
| 2018-04-23 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-04-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-02-07 | Reiterato | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Aggiornamento | SunTrust | Hold → Buy |
Mostra tutto
Merck Co Inc Borsa (MRK) Ultime notizie
Vanguard Group Inc. Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Supplemental Annuity Collective Trust of NJ - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Sanctuary Advisors LLC - MarketBeat
Impax Asset Management Group plc Decreases Stock Position in Merck & Co., Inc. $MRK - MarketBeat
M&T Bank Corp Sells 1,452,939 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stake Increased by AEGON ASSET MANAGEMENT UK Plc - MarketBeat
Merck and the Healthcare Sector Rotation Analysis - HarianBasis.co
Merck & Co., Inc. $MRK is Munich Reinsurance Co Stock Corp in Munich's 4th Largest Position - MarketBeat
J.P. Marvel Investment Advisors LLC Has $3.02 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Concurrent Investment Advisors LLC Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Generali Investments Management Co LLC Raises Stock Position in Merck & Co., Inc. $MRK - MarketBeat
China Universal Asset Management Co. Ltd. Sells 19,894 Shares of Merck & Co., Inc. $MRK - MarketBeat
Jim Cramer Says “Merck Is Terrific” - Yahoo Finance
MRK Stock Quote Price and Forecast - CNN
Is Merck & Co. (MRK) One of the Best Bear Market Stocks to Invest in Right Now? - Insider Monkey
Infinimmune and Merck (MRK) Enter into an Antibody Discovery Agreement - insidermonkey.com
Merck & Co Inc (MRK) Stock Price, Trades & News - GuruFocus
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, - PharmiWeb.com
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc. - BioSpace
Mental Health Clinical Trials Research Report 2026: $4.89 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F - GlobeNewswire Inc.
Merck & Co., Inc. $MRK Shares Purchased by Cadinha & Co. LLC - MarketBeat
Arizona State Retirement System Sells 31,306 Shares of Merck & Co., Inc. $MRK - MarketBeat
MRK Stock Price, Quote & Chart | MERCK & CO. INC. (NYSE:MRK) - ChartMill
Merck & Co. Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Merck & Co., Inc. $MRK Shares Sold by Teacher Retirement System of Texas - MarketBeat
United Asset Strategies Inc. Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (MRK) Gains FDA Priority Review for KEYTRUDA Regimen in Muscle-Invasive Bladder Cancer - Insider Monkey
Merck & Co., Inc. $MRK Shares Bought by Caprock Group LLC - MarketBeat
B. Metzler seel. Sohn & Co. AG Increases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (MRK) to Release Earnings on Thursday - MarketBeat
Merck & Co. Inc. (MRK) Poised to Drive R&D and Operational Efficiency via New Google Cloud Agentic AI PartnershipUpside Surprise - Xã Thanh Hà
Merck & Co (MRK) Proxy filing Summary - Quartr
Merck to partner with Google Cloud on AI initiatives - Reuters
Merck & Co., Inc. $MRK Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
KLP Kapitalforvaltning AS Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Has $4.84 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
PFG Advisors Sells 11,759 Shares of Merck & Co., Inc. $MRK - MarketBeat
CPC Advisors LLC Increases Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Boston Trust Walden Corp - MarketBeat
Merck & Co., Inc. (MRK)Phase 3 Oncology Trial Setback Triggers Near-Term Pullback, Long-Term Upside Remains IntactNet Debt/EBITDA - Cổng thông tin điện tử tỉnh Tây Ninh
A Look at Merck & Co Inc (MRK) After 3.9% Decline -- GF Value $1 - GuruFocus
Merck And Eisai’s Keytruda/Lenvima/Welireg Trial In Kidney Cancer Fails - Citeline News & Insights
US FDA approves Merck's pill combo to treat HIV infection - Reuters
Merck's new once-daily HIV pill hits pharmacies after FDA nod - Stock Titan
FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir) - Business Wire
Why Is Merck Stock Falling Tuesday? - Benzinga
FDA grants priority review to Merck-Daiichi’s B7-H3 cancer ADC - BioWorld News
Merck & Co Inc Stock (MRK) Moved Down by 4.19% on Apr 21: A Full Analysis - TradingKey
Merck Rises 11% YTD: Should Investors Buy, Sell or Hold the Stock? - TradingView
Novem Group Purchases 9,205 Shares of Merck & Co., Inc. $MRK - MarketBeat
SageGuard Financial Group LLC Acquires Shares of 14,280 Merck & Co., Inc. $MRK - MarketBeat
Merck Co Inc Azioni (MRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.36%
6.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):